Black Rock Inc. Adma Biologics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 18,644,711 shares of ADMA stock, worth $422 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,644,711
Previous 18,199,277
2.45%
Holding current value
$422 Million
Previous $120 Million
73.54%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ADMA
# of Institutions
301Shares Held
180MCall Options Held
535KPut Options Held
21.2K-
Vanguard Group Inc Valley Forge, PA14.5MShares$328 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$298 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$202 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$182 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.82MShares$154 Million0.08% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.44B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...